Current through Register 1538, January 3, 2025
Section 164.612 - Minimum Treatment Service RequirementsThe Approved Provider shall provide directly or through QSOAs the following services:
(A) Medications for treatment of addiction, including all FDA-approved medications for addiction treatment;(B) Overdose prevention education as part of evidence-based practices;(C) Substance use disorder therapies;(D) Counseling and education as clinically indicated which conform to accepted standards of care, uses evidence-based practices, and monitors progress and outcomes;(E) Case management including: (1) directly connecting patients and residents to appropriate providers based on continuum of care and patient and resident educational, vocational, financial, legal and housing, and(2) updating the patient or resident's primary care provider on treatment and progress, such as by providing the patient's or resident's record to the primary care provider upon the patient's or resident's documented authorization.(3) documentation of patient or resident consent to provide treatment information to the patient or resident's primary care provider or release information to the receiving provider prior to or upon patient transfer. In the event the patient or resident refuses such consent, the Licensed or Approved Provider shall document such refusal in the patient or resident's record.(F) Relapse prevention and recovery maintenance counseling and education and shall: (1) include monitoring of the patient's or resident's behavior;(2) address risks specific to the patient or resident, including, where applicable, risk of overdose; and(3) include services intended to maintain the patient or resident in treatment and support recovery; and(G) Planning for patient's or resident's completion of treatment, and identification of transitional, discharge and aftercare supports the patient or resident may require.Adopted by Mass Register Issue 1482, eff. 11/11/2022.